Chronic Pain

Multiple Sclerosis Rehabilitation: From Impairment to Participation

Volumn , Issue , 2012, Pages 199-226

  Ehde, Dawn M ^a   Kratz, Anna L ^b   Robinson, James P ^a   Jensen, Mark P ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85126272628     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/b12666-14     Document Type: Chapter

References (124)

1. Ehde DM, Osborne TL, Hanley MA, Jensen MP, Kraft GH. The scope and nature of pain in persons with multiple sclerosis. Multiple Sclerosis 2006;12(5):629-638.
2. Hadjimichael O, Kerns RD, Rizzo MA, Cutter G, Vollmer T. Persistent pain and uncomfortable sensations in persons with multiple sclerosis. Pain 2007;127(1-2):35-41.
3. Khan F, Pallant J. Chronic pain in multiple sclerosis: Prevalence, characteristics, and impact on quality of life in an Australian community cohort. Journal of Pain 2007;8(8):614-623.
4. Ehde DM, Gibbons LE, Chwastiak L, Bombardier CH, Sullivan MD, Kraft GH. Chronic pain in a large community sample of persons with multiple sclerosis. Multiple Sclerosis 2003;9(6):605-611.
5. O’Connor AB, Schwid SR, Herrmann DN, Markman JD, Dworkin RH. Pain associated with multiple sclerosis: Systematic review and proposed classification. Pain 2008;137(1):96-111.
6. Grasso MG, Clemenzi A, Tonini A, Pace L, Casillo P, Cuccaro A, Pompa A, Troisi E. Pain in multiple sclerosis: A clinical and instrumental approach. Multiple Sclerosis 2008;14(4):506-513.
7. Archibald CJ, McGrath PJ, Ritvo PG, Fisk JD, Bhan V, Maxner CE, Murray TJ. Pain prevalence, severity and impact in a clinic sample of multiple sclerosis patients. Pain 1994;58(1):89-93.
8. Rae-Grant AD, Eckert NJ, Bartz S, Reed JF. Sensory symptoms of multiple sclerosis: A hidden reservoir of morbidity. Multiple Sclerosis 1999;5(3):179-183.
9. Novy DM, Nelson CV, Francis DJ, Turk DC. Perspectives of chronic pain: An evaluative comparison of restrictive and comprehensive models. Psychological Bulletin 1995;118:238-247.
10. Boothby JL, Thorn BE, Stroud MW, Jensen MP. Coping with pain. In: D. C. Turk, R. J. Gatchel, editors. Psychosocial factors in pain. New York, NY: Guilford Press; 1999.
11. Sullivan MJ, Thorn B, Haythornthwaite JA, Keefe FJ, Martin M, Bradley LA, Lefebvre JC. Theoretical perspectives on the relation between catastrophizing and pain. Clinical Journal of Pain 2001;17:52-64.
12. Keefe FJ, Rumble ME, Scipio CD, Giordano LA, Perri LM. Psychological aspects of persistent pain: Current state of the science. The Journal of Pain 2004;5:195-211.
13. Jensen MP, Moore MR, Bockow TB, Ehde DM, Engel JM. Psychosocial factors and adjustment to chronic pain in persons with physical disabilities: A systematic review. Archives of Physical Medicine and Rehabilitation 2011;92:146-160.
14. Osborne TL, Jensen MP, Ehde DM, Hanley MA, Kraft G. Psychosocial factors associated with pain intensity, pain-related interference, and psychological functioning in persons with multiple sclerosis and pain. Pain 2007;127(1-2):52-62.
15. Douglas C, Wollin JA, Windsor C. Biopsychosocial correlates of adjustment to pain among people with multiple sclerosis. The Clinical Journal of Pain 2008;24:559-567.
16. Attal N, Bouhassira D. Can pain be more or less neuropathic? Pain 2004;110:510-511.
17. Pollman W, Feneberg W. Current management of pain associated with multiple sclerosis. CNS Drugs 2008;22:291-324.
18. Osterberg A, Boivie J, Thuomas KA. Central pain in multiple sclerosis-Prevalence and clinical characteristics. European Journal of Pain 2005;9(5):531-542.
19. Finnerup NB. A review of central neuropathic pain states. Current Opinion in Anaesthesiology 2008;21:586-589.
20. Murray PD, Masri R, Keller A. Abnormal anterior pretectal nucleus activity contributes to central pain syndrome. Journal of Neurophysiology 2010;103:3044-3053.
21. Solaro C, Brichetto G, Amato MP, Cocco E, Colombo B, D’Aleo G, Gasperini C, Ghezzi A, Martinelli V, Quessy S. The prevalence of pain in multiple sclerosis: A multicenter cross-sectional study. Neurology 2004;63(5):919-921.
22. Al-Araji AH, Oger J. Reappraisal of Lhermitte’s sign in multiple sclerosis. Multiple Sclerosis 2005;11(4):398-402.
23. Hooge JP, Redekop WK. Trigeminal neuralgia in multiple sclerosis. Neurology 1995;45(7):1294-1296.
24. Chen L, Gordon LK. Ocular manifestations of multiple sclerosis. Current Opinion in Ophthalmology 2005;16:315-320.
25. Beard S, Hunn A, Wight J. Treatments for spasticity and pain in multiple sclerosis: A systematic review. Health Technology Assessment 2003;7:iii, ix-x, 1-111.
26. Boneschi FM, Colombo B, Annovazzi P, Martinelli V, Bernasconi L, Solaro C, Comi G. Lifetime and actual prevalence of pain and headache in multiple sclerosis. Multiple Sclerosis 2008;14(4):514-521.
27. Warnell P. The pain experience of a multiple sclerosis population: A descriptive study. Axone 1991;13(1):26-28.
28. Brochet B, Deloire MS, Ouallet JC, Salort E, Bonnet M, Jové J, Petry KG. Pain and quality of life in the early stages after multiple sclerosis diagnosis: A 2-year longitudinal study. Clinical Journal of Pain 2009;25(3):211-217.
29. Svendsen KB, Jensen TS, Hansen HJ, Bach FW. Sensory function and quality of life in patients with multiple sclerosis and pain. Pain 2005;114(3):473-481.
30. Douglas C, Wollin J, Windsor C. The impact of pain on the quality of life of people with multiple sclerosis: A community survey. International Journal of Multiple Sclerosis Care 2009;11:127-136.
31. Svendsen KB, Jensen TS, Overvad K, Hansen HJ, Koch-Henriksen N, Bach FW. Pain in patients with multiple sclerosis: A population-based study. Archives of Neurology 2003;60(8):1089-1094.
32. Newland PK, Naismith RT, Ullione M. The impact of pain and other symptoms on quality of life in women with relapsing-remitting multiple sclerosis. Journal of Neuroscience Nursing 2009;41(6):322-328.
33. Kalia LV, O’Connor PW. Severity of chronic pain and its relationship to quality of life in multiple sclerosis. Multiple Sclerosis 2005;11(3):322-327.
34. Murray TJ. The psychosocial aspects of multiple sclerosis. Neurology Clinics 1995;13(1):197-223.
35. Douglas C, Windsor C, Wollin J. Understanding chronic pain complicating disability: Finding meaning through focus group methodology. Journal of Neuroscience Nursing 2008;40(3):158-168.
36. Dworkin RH, Turk DC, Farrar JT, Haythornthwaite JA, Jensen MP, Katz NP, Kerns RD, Stucki G, Allen RR, Bellamy N et al. Core outcome measures for chronic pain clinical trials: IMMPACT recommendations. Pain 2005;113:9-19.
37. Price DD, Harkins SW, Baker C. Sensory-affective relationships among different types of clinical and experimental pain. Pain 1987;28(3):297-307.
38. Melzack R. The McGill Pain Questionnaire: Major properties and scoring methods. Pain 1975;1:277-299.
39. Melzack R. The short-form McGill Pain Questionnaire. Pain 1987;30:191-197.
40. Jensen MP, Karoly P. Self-report scales and procedures for assessing pain in adults. In: D. C. Turk, R. Melack, editors. Handbook of pain assessment. 3rd ed. New York, NY: Guilford Press; 2011.
41. Jensen MP. Using pain quality assessment measures for selecting analgesic agents. The Clinical Journal of Pain 2006;22 Suppl:S9-S13.
42. Jensen MP. Measurement of pain. In: S. M. Fishman, J. C. Ballantyne, J. P. Rathmell, editors. Bonica’s management of pain. 4th ed. Media, PA: Williams and Wilkins; 2010.
43. Bennett M. The LANSS pain scale: The Leeds Assessment of Neuropathic Symptoms and Signs. Pain 2001;92:147-157.
44. Bennett MI, Smith BH, Torrance N, Potter J. The S-LANSS score for identifying pain of predominantly neuropathic origin: Validation for the use in clinical and postal research. Journal of Pain 2005;6:149-158.
45. Galer BS, Jensen MP. Development and preliminary validation of a pain measure specific to neuropathic pain: The Neuropathic Pain Scale. Neurology 1997;48:332-338.
46. Jensen MP, Gammaitoni AR, Olaleye DO, Oleka N, Nalamachu SR, Galer BS. The Pain Quality Assessment Scale: Assessment of pain quality in carpal tunnel syndrome. Journal of Pain 2006;7:823-832.
47. Margolis RB, Tait RC, Krause SJ. A rating system for use with patient pain drawings. Pain 1986;24:57-65.
48. Cleeland CS, Ryan KM. Pain assessment: Global use of the brief pain inventory. Annals of the Academy of Medicine 1994;23:129-138.
49. Spitzer RL, Kroenke K, Williams JBW. Validation and utility of a self-report version of the PRIME-MD. Journal of the American Medical Association 1999;282:1737-1744.
50. Turk DC, Melack R. Handbook of pain assessment. 3rd ed. New York: Guilford Press; 2011.
51. Robinson JP, Apkarian AV. Low back pain. In: E. A. Mayer, M. C. Bushnell, editors. Functional pain syndromes: Presentation and pathophysiology. Seattle, WA: IASP Press; 2009.
52. Wasiak R, Young AE, Dunn KM, Côté P, Gross DP, Heymans MW, von Korff M. Back pain recurrence: An evaluation of existing indicators and direction for future research. Spine 2009;34(9):970-977.
53. Bouhassira D, Attal N, Fermanian J, Alchaar H, Gautron M, Masquelier E, Rostaing S, Lanteri-Minet M, Collin E, Grisart J et al. Development and validation of the neuropathic pain symptom inventory. Pain 2004;108:248-257.
54. Asbury AK, Fields HJ. Pain due to peripheral nerve damage: An hypothesis. Neurology 1984;34:1587-1590.
55. Hackett GS, Hemwall GA, Montgomery GA. Ligament and tendon relaxation treated by prolotherapy. Oak Park, IL: Hemwall; 1993.
56. Simons DG, Travell J, Simons LS. Travell and Simons’ myofascial pain dysfunction: The trigger point manual. Baltimore, MD: Williams and Wilkins; 1999.
57. Agency Medical Directors’ Group. Interagency guideline on opioid dosing for chronic non-cancer pain: An educational aid to improve care and safety with opioid therapy. Olympia, WA: Washington State Agency Medical Directors Group; 2010.
58. Rossi S, Mataluni G, Codecà C, Fiore S, Buttari F, Musella A, Castelli M, Bernardi G, Centonze D. Effects of levetiracetam on chronic pain in multiple sclerosis: Results of a pilot, randomized, placebo-controlled study. European Journal of Neurology 2009;16:360-366.
59. Silver M, Blum D, Grainger J, Hammer AE, Quessy S. Double-blind, placebo-controlled trial of lamotrigine in combination with other medications for neuropathic pain. Journal of Pain and Symptom Management 2007;34:446-454.
60. Breuer B, Pappagallo M, Knotkova H, Guleyupoglu N, Wallenstein S, Portenoy RK. A randomized, double-blind, placebo-controlled, two-period, crossover, pilot trial of lamotrigine in patients with central pain due to multiple sclerosis. Clinical Therapeutics 2007;29:2022-2030.
61. Keskinbora K, Pekel AF, Aydinli I. Gabapentin and an opioid combination versus opiod alone for the management of neuropathic cancer pain: A randomized open trial. Journal of Pain and Symptom Management 2007;34:183-189.
62. Yaksi A, Ozgönenel L, Ozgönenel B. The efficacy of gabapentin therapy in patients with lubar spinal stenosis. Pain 2011;152:939-942.
63. van de Vusse, AC, Stomp-van den Berg, SG, Kessels AH, Weber WE. Randomised controlled trial of gabapentin in complex regional pain syndrome type 1. BMC Neurology 2004 September;4:13.
64. Caraceni A, Zecca E, Bonezzi C, Arcuri E, Yaya Tur R, Maltoni M, Visentin M, Gorni G, Martini C, Tirelli W et al. Gabapentin for neuropathic cancer pain: A randomized controlled trial from the gabapentin cancer pain study group. Journal of Clinical Oncology 2004;22:2909-2917.
65. Levendoglu F, Ogün CO, Ozerbil O, Ogün TC, Ugurlu H. Gabapentin is a first line drug for the treatment of neuropathic pain in spinal cord injury. Spine 2004;29:743-751.
66. Serpell, MG and Neuropathic Pain Study Group. Gabapentin in neuropathic pain syndromes: A randomised, double-blind, placebo-controlled trial. Pain 2002;99:557-566.
67. Arezzo JC, Rosenstock J, Lamoreaux L, Pauer L. Efficacy and safety of pregabalin 600 mg/d for treating painful diabetic peripheral neuropathy: A double-blind placebo-controlled trial. BMC Neurology 2008 September;8:33.
68. Tölle T, Freynhagen R, Versavel M, Trostmann U, Young JPJ. Pregabalin for relief of neuropathic pain associated with diabetic neuropathy: A randomized, double-blind study. European Journal of Pain 2008;12:203-213.
69. Siddall PJ, Cousins MJ, Otte A, Griesing T, Chambers R, Murphy TK. Pregabaline in central neuropathic pain associated with spinal cord injury: A placebo-controlled trial. Neurology 2006;67:1792-1800.
70. Freynhagen R, Strojek K, Griesing T, Whalen E, Balkenohi M. Efficacy of pregabalin in neuropathic pain evaluated in a 12-week, randomised, double-blind, multicentre, placebo-controlled trial of flexible-and fixed-dose regimens. Pain 2005;115:254-263.
71. Vranken JH, Dijkgraaf MG, Kruis MR, van der Vegt, MH, Hollmann MW, Heesen M. Pregabalin in patients with entral neuropathic pain: A randomized, double-blind, placebo-controlled trial of a flexible-dose regimen. Pain 2008;136:150-157.
72. Solaro C, Restivo D, Mancardi GL, Tanganelli P. Oxcarbazepine for treating paroxysmal painful symptoms in multiple sclerosis: A pilot study. Neurological Sciences 2007;28:156-158.
73. Attal N, Cruccu G, Haanpaa M, Hansson P, Jensesn TS, Nurmikko T, Sampaio C, Sindrup S, Wiffen P. EFNS guidelines on pharmacological treatment of neuropathic pain. European Journal of Neurology 2006;13:1153-1169.
74. Dworkin RH, O’Connor AB, Backonja M, Farrar JT, Finnerup NB, Jensen TS, Kalso EA, Loeser JD, Miaskowski C, Nurmikko TJ et al. Pharmacologic management of neuropathic pain: Evidence-based recommendations. Pain 2007;132(3):237-251.
75. Saarto T, Wiffen PJ. Antidepressants for neuropathic pain: A Cochrane review. Journal of Neurology, Neurosurgery, and Psychiatry 2010;81(12):1372-1373.
76. Cutter NC, Scott DD, Johnson JC, Whiteneck G. Gabapentin effect on spasticity in multiple sclerosis: A placebo-controlled, randomized trial. Archives of Physical Medicine and Rehabilitation 2000;81:164-169.
77. Kalman S, Osterberg A, Sorensen J, Boivie J, Bertler A. Morphine responsiveness in a group of well-defined multiple sclerosis patients: A study with i.v. morphine. European Journal of Pain 2002;6:69-80.
78. Angst, MS, and Clark, JD. Opioid-induced hyperalgesia: A qualitative systematic review. Anesthesiology 2006;104:570-587.
79. Rahn EJ, Hohmann AG. Cannabinoids as pharmacotherapies for neuropathic pain: From the bench to the bedside. Neurotherapeutics 2009;6:713-737.
80. Howlett AC. Pharmacology of cannabinoid receptors. Annual Review of Pharmacology and Toxicology 1995;35:607-634.
81. Freund TF, Katona I, Piomelli D. Role of endogenous cannabinoids in synaptic signaling. Physiological Reviews 2003;83:1017-1066.
82. Zajicek JP, Apostu VI. Role of cannabinoids in multiple sclerosis. CNS Drugs 2011 2011;25(3):187-201.
83. Wade DT, Makela P, Robson P, House H, Bateman C. Do cannabis-based medicinal extracts have general or specific effects on symptoms in multiple sclerosis? A double-blind, randomized, placebo-controlled study on 160 patients. Multiple Sclerosis 2004;10:434-441.
84. White LJ, Dressendorfer RH. Exercise and multiple sclerosis. Sports Medicine 2004;34(15):1077-1100.
85. Motl RW, Gosney JL. Effect of exercise training on quality of life in multiple sclerosis: A meta-analysis. Multiple Sclerosis 2008;14(1):129-135.
86. Motl RW, McAuley E. Pathways between physical and quality of life in adults with multiple sclerosis. Health Psychology 2009;28(6):682-689.
87. Motl RW, McAuley E, Snook EM, Gliottoni RC. Physical activity and quality of life in multiple sclerosis: Intermediary roles of disability, fatigue, mood, pain, self-efficacy and social support. Psychology, Health and Medicine 2009;14(1):111-124.
88. Motl RW, McAuley E, Snook EM. Physical activity and multiple sclerosis: A meta-analysis. Multiple Sclerosis 2005;11(4):459-463.
89. Rietberg MB, Brooks D, Uitdehaag BM, Kwakkel G. Exercise therapy for multiple sclerosis. Cochrane Database of Systematic Reviews 2004 09(3).
90. Fordyce WE. Behavioral methods for chronic pain and illness. St. Louis: C.V. Mosby; 1976.
91. Turk DC, Gatchel RJ. Psychological approaches to pain management: A practitioner’s handbook. 2nd ed. New York, NY: Guilford Press; 2002.
92. Esdaile J. Hypnosis in medicine and surgery. New York: Julian Press; 1957.
93. Jensen MP. Chronic pain. In: A. Barabasz, K. Olness, R. Boland, S. Kahn, editors. Evidence-based medical hypnosis: A primer for health care professionals. New York, NY: Routledge; 2009.
94. Hofbauer RK, Rainville P, Duncan GH, Bushnell MC. Cortical representation of the sensory dimension of pain. Journal of Neurophysiology 2001;86:402-411.
95. Rainville P, Duncan GH, Price DD, Carrier B, Bushnell MC. Pain affect encoded in human anterior cingulate but not somatosensory cortex. Science 1997;277:968-971.
96. Jensen MP, Patterson DR. Hypnotic treatment of chronic pain. Journal of Behavioral Medicine 2006;29:95-124.
97. Green JP, Barabasz AF, Barrett D, Montgomery GH. Forging ahead: The 2003 APA division 30 definition of hypnosis. International Journal of Clinical and Experimental Hypnosis 2005;53:259-264.
98. Jensen MP, Patterson DR. Hypnosis in the relief of pain and pain disorders. In: M. R. Nash, A. Barnier, editors. Contemporary hypnosis research. 2nd ed. Oxford, UK: Oxford University Press; 2008.
99. Jensen MP, Barber J, Romano JM, Molton IR, Raichle KA, Osborne TL, Engel JM, Stoelb BL, Kraft GH, Patterson DR. A comparison of self-hypnosis versus progressive muscle relaxation in patients with multiple sclerosis and chronic pain. International Journal of Clinical and Experimental Hypnosis 2009;57(2):198-221.
100. Jensen MP, Hanley MA, Engel JM, Romano JM, Barber J, Cardenas DD, Kraft GH, Hoffman AJ, Patterson DR. Hypnotic analgesia for chronic pain in persons with disabilities: A case series. International Journal of Clinical and Experimental Hypnosis 2005;53:198-228.
101. Jensen MP, McArthur KD, Barber J, Hanley MA, Engel JM, Romano JM, Cardenas DD, Kraft GH, Hoffman AJ, Patterson DR. Satisfaction with, and the beneficial side effects of, hypnotic analgesia. International Journal of Clinical and Experimental Hypnosis 2006;54:432-447.
102. Jensen MP, Ehde DM, Gertz KJ, Stoelb BL, Dillworth TM, Hirsh AT, Molton IR, Kraft GH. Effects of self-hypnosis training and cognitive restructuring on daily pain intensity and catastrophizing in individuals with multiple sclerosis and chronic pain. International Journal of Clinical and Experimental Hypnosis 2011;59(1):45-63.
103. Jensen MP. Hypnosis for chronic pain management: Therapist guide (treatments that work). USA: Oxford University Press; 2011.
104. Patterson DR. Clinical hypnosis for pain control. Washington, D.C.: American Psychological Association; 2010.
105. Beck AT. Cognitive therapy and the emotional disorders. New York: International Universities Press; 1976.
106. Norton PJ, Price EC. A meta-analytic review of adult cognitive-behavioral treatment outcome across the anxiety disorders. Journal of Nervous and Mental Disorders 2007;195(6):521-531.
107. Tolin DF. Is cognitive-behavioral therapy more effective than other therapies? A meta-analytic review. Clinical Psychology Review 2010;30:710-720.
108. Thorn BE. Cognitive therapy for chronic pain: A step-by-step guide. New York, NY: Guilford Press; 2004.
109. Butler AC, Chapman JE, Forman EM, Beck AT. The empirical status of cognitive-behavioral therapy: A review of meta-analyses. Clinical Psychology Review 2006;26(1):17-31.
110. Hoffman BM, Papas RK, Chatkoff DK, Kerns RD. Meta-analysis of psychological interventions for chronic low back pain. Health Psychology 2007;26(1):1-9.
111. Henschke N, Ostelo RW, van Tulder M, Vlaeyen JW, Morley S, Assendelft WJ, Main CJ. Behavioural treatment for chronic low-back pain. Cochrane Database of Systematic Reviews 2010 07(7).
112. Ehde DM, Jensen MP. Feasibility of a cognitive restructuring intervention for treatment of chronic pain in persons with disabilities. Rehabilitation Psychology 2004;49:254-258.
113. Otis JD. Managing chronic pain: A cognitive-behavioral therapy approach (treatments that work). Oxford, UK: Oxford University Press; 2007.
114. Grossman P, Kappos L, Gensicke H, D’Souza M, Mohr DC, Penner IK, Steiner C. MS quality of life, depression, and fatigue improve after mindfulness training: A randomized trial. Neurology 2010;75:1141-1149.
115. Hayes SC, Strosahl KD, Wilson KG. Acceptance and commitment therapy: An experimental approach to behavior change. New York, NY: Guilford Press; 1999.
116. Sheppard SC, Forsyth JP, Hickling EJ, Bianchi J. A novel application of acceptance and commitment therapy for psychosocial problems associated with multiple sclerosis. International Journal of MS Care 2010;12:200-206.
117. Veehof MM, Oskam MJ, Schreurs KM, Bohlmeijer ET. Acceptance-based intervention for the treatment of chronic pain: A systematic review and meta-analysis. Pain 2011;152:533-542.
118. Wren AA, Wright MA, Carson JW, Keefe FJ. Yoga for persistent pain: New findings and directions for an ancient practice. Pain 2011;152:477-480.
119. Oken BS, Kishiyama S, Zajdel D, Bourdette D, Carlsen J, Haas M, Hugos C, Kraemer DF, Lawrence J, Mass M. Randomized controlled trial of yoga and exercise in multiple sclerosis. Neurology 2004;62:2058-2064.
120. Patti F, Ciancio MR, Reggio E, Lopes R, Palermo F, Cacopardo M, Reggio A. The impact of outpatient rehabilitation on quality of life in multiple sclerosis. Journal of Neurology 2002;249:1027-1033.
121. Bombardier CH, Cunniffe M, Wadhwani R, Gibbons LE, Blake KD, Kraft GH. The efficacy of telephone counseling for health promotion in people with multiple sclerosis: A randomized controlled trial. Archives of Physical Medicine and Rehabilitation 2008;89:1849-1856.
122. Thorn BE, Burns JW. Common and specific treatment mechanisms in psychosocial pain interventions: The need for a new research agenda. Pain 2011;152(4):705-706.
123. Turner JA, Cardenas DD, Warms CA, McClellan CB. Chronic pain associated with spinal cord injuries: A community survey. Archives of Physical Medicine and Rehabilitation 2001 04;82(4):501-508.
124. Warms CA, Turner JA, Marshall HM, Cardenas DD. Treatments for chronic pain associated with spinal cord injuries: Many are tried, few are helpful. Clinical Journal of Pain 2002;18:154-163.